|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| HDL Cholesterol - Metabolic Pathways and Drug Development | ||||||||||||||||
| October 11, 2000 | ||||||||||||||||
|
The Knowledge Foundation, Inc., Boston, MA, USA Februray 12-13, 2001 During the 1st international conference, significant advances were presented towards the research and development of effective therapeutics for elevating the HDL Cholesterol level and lowering the risk of coronary heart disease. Once again, the 2001 conference showcases leading academic and industry researchers from around the world who will present the latest in exciting new discoveries to influence the HDL Cholesterol metabolic pathway, including such areas as: Transfer proteins and receptors * New CETP inhibitors * Lipoprotein receptors as drug targets Transcription Factors and Nuclear Receptors * RXR as a possible drug discovery target * The role of PPAR in cardiovascular diseases Clinical and genetic studies * HATS ¥ VA-HIT ¥ Genetic variations ABC1 Transporter Protein Expression and regulation of ABC1 * cellular trafficking of ABC1 Scavenger Receptor B Type 1 * Binding capacities, variants and regulation * SRB1 and reverse cholesterol transport Take advantage of this annual event designed specifically to give you the latest insight and in-depth information about the research in progress to develop novel therapeutic approaches for cardiovascular disease. Register early to reserve your place! |
||||||||||||||||
| Organized by: | The Knowledge Foundation, Inc. | |||||||||||||||
| Invited Speakers: | GM Anantharamaiah, University of Alabama W. Scott Argraves, Medical University of South Carolina Ben Bowen, Novartis Kevin W. Buchan, Glaxo Wellcome, UK Y Chao, Merck Research Laboratories Omar L. Francone, Pfizer Central Research Robert Hegele, University of Western Ontario, Canada Karen F. Kozarsky, SmithKline Beecham Pharmaceuticals Mark D. Leibowitz, Ligand Pharmaceuticals Thomas Logan, Millennium Pharmaceuticals Edward B. Neufeld, NIH Andrew C. Nicholson, Cornell University Medical College John F. Oram, University of Washington Jose M. Ordovas, Tufts University Attilio Rigotti, Catholic University, Chile Sander Robins, Boston University School of Medicine James A. Sikorski, Pharmacia Discovery Research Jonathan D. Smith, The Rockefeller University Bart Staels, INSERM, France Korekiyo Wakitani, Japan Tobacco Inc, Japan X Zhao, University of Washington |
|||||||||||||||
| Deadline for Abstracts: | January 21, 2001 | |||||||||||||||
| Registration: | for registration contact custserv@knowledgefoundation.com or register online at www.knowledgefoundation.com |
|||||||||||||||
| E-mail: | custserv@knowledgefoundation.com | |||||||||||||||
| Posted by: | Margit Eder | |||||||||||||||
| Host: | wks154.knowledgefoundation.com | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||